Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
| Distributed by / for | Beacon Hill Medical Pharmacy, P.C. |
| Full product label | POTASSIUM CHLORIDE 2 MEQ/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI |
| Recalling firm | Beacon Hill Medical Pharmacy, P.C. |
| Distribution | USA nationwide |
| Quantity | N/A |
| Recall initiated | 2013-07-26 |
| Report date | 2013-09-18 |
| Recall completed | 2014-07-18 |
| Recall number | D-989-2013 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Southfield MI United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗